Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Vical deal

Vical Inc. (VICL)
Vical Inc. (VICL) said Merck & Co. Inc.

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE